Li, H.;                     Li, J.-j.;                     Lu, W.;                     Yang, J.;                     Xia, Y.;                     Huang, P.    
        Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines 2023, 11, 475.
    https://doi.org/10.3390/biomedicines11020475
    AMA Style
    
                                Li H,                                 Li J-j,                                 Lu W,                                 Yang J,                                 Xia Y,                                 Huang P.        
                Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines. 2023; 11(2):475.
        https://doi.org/10.3390/biomedicines11020475
    
    Chicago/Turabian Style
    
                                Li, He,                                 Jiang-jiang Li,                                 Wenhua Lu,                                 Jing Yang,                                 Yunfei Xia,                                 and Peng Huang.        
                2023. "Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism" Biomedicines 11, no. 2: 475.
        https://doi.org/10.3390/biomedicines11020475
    
    APA Style
    
                                Li, H.,                                 Li, J.-j.,                                 Lu, W.,                                 Yang, J.,                                 Xia, Y.,                                 & Huang, P.        
        
        (2023). Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines, 11(2), 475.
        https://doi.org/10.3390/biomedicines11020475